Clain, Alisabet

l -Methylfolate as Adjunctive Therapy for SSRI-Resistant Major Depression: Results of Two Randomized, Double-Blind, Parallel-Sequential Trials

Papakostas, G. I., Shelton, R. C., Zajecka, J. M., Etemad, B., Rickels, K., Clain, A., Baer, L., Dalton, E. D., Sacco, G. R., Schoenfeld, D., et al. (2012) · American Journal of Psychiatry

Treatment of Major DepressionFolate and B Vitamins Research

Cited by 275

Residual symptoms after remission of major depressive disorder with fluoxetine and risk of relapse

Iovieno, N., van Nieuwenhuizen, A., Clain, A., Baer, L., & Nierenberg, A. A. (2011) · Depression and Anxiety

Treatment of Major DepressionAnxiety, Depression, Psychometrics, Treatment, Cognitive Processes

Cited by 98

Association Between Patient Beliefs Regarding Assigned Treatment and Clinical Response: Reanalysis of Data From the Hypericum Depression Trial Study Group

Chen, J. A., Papakostas, G. I., Youn, S. J., Baer, L., Clain, A. J., Fava, M., & Mischoulon, D. (2011) · The Journal of Clinical Psychiatry

Pain Management and Placebo EffectPsychotherapy Techniques and Applications

Cited by 56

Omega-3 Fatty Acids for Major Depressive Disorder With High Inflammation: A Randomized Dose-Finding Clinical Trial

Mischoulon, D., Dunlop, B. W., Kinkead, B., Schettler, P. J., Lamon-Fava, S., Rakofsky, J. J., Nierenberg, A. A., Clain, A. J., Crowe, T. M., Wong, A., et al. (2022) · The Journal of Clinical Psychiatry

Fatty Acid Research and HealthTryptophan and brain disorders

Cited by 56

Type of residual symptom and risk of relapse during the continuation/maintenance phase treatment of major depressive disorder with the selective serotonin reuptake inhibitor fluoxetine

Yang, H., Chuzi, S., Sinicropi-Yao, L., Johnson, D., Chen, Y., Clain, A., Baer, L., McGrath, P. J., Stewart, J. W., Fava, M., et al. (2010) · European Archives of Psychiatry and Clinical Neuroscience

Treatment of Major DepressionAnxiety, Depression, Psychometrics, Treatment, Cognitive Processes

Cited by 42

Anxious depression and early changes in the HAMD-17 anxiety-somatization factor items and antidepressant treatment outcome.

Farabaugh, A. H., Bitran, S., Witte, J., Alpert, J., Chuzi, S., Clain, A. J., Baer, L., Fava, M., McGrath, P. J., Dording, C., et al. (2010) · International Clinical Psychopharmacology

Treatment of Major DepressionAnxiety, Depression, Psychometrics, Treatment, Cognitive Processes

Cited by 37

Efficacy of ziprasidone monotherapy in patients with anxious depression: a 12-week, randomized, double-blind, placebo-controlled, sequential-parallel comparison trial

Heo, J.-Y., Jeon, H. J., Fava, M., Mischoulon, D., Baer, L., Clain, A., Doorley, J., Pisoni, A., & Papakostas, G. I. (2015) · Journal of Psychiatric Research

Treatment of Major DepressionAnxiety, Depression, Psychometrics, Treatment, Cognitive Processes

Cited by 6